EUROPE AND ISRAEL MOBILE APPLICATIONS FOR MELANOMA DETECTION MARKET ANALYSIS

Europe And Israel Mobile Applications For Melanoma Detection MarketSize and Trends

Europe and Israel Mobile Applications for Melanoma Detection Market

Europe and Israel mobile applications for melanoma detection market is estimated to be valued at US$ 1.1 million in 2021 and is expected to exhibit a CAGR of 19.6 % over the forecast period (2021-2028).

Figure 1. Europe and Israel Mobile Applications for Melanoma Detection Market Value (US$ Mn), by Region, 2020

Market Trends

Development of new technologies is expected to propel growth of the Europe and Israel mobile applications for melanoma detection market. For instance, in December 2019, Denmark-based company Miiskin reported development of AI-powered skin mapping technology to detect early warning signs of melanoma.

The market in Europe is witnessing approval and launch of new therapies. For instance, in May 2020, OncoSec Medical Inc., a company developing late-stage intratumoral cancer immunotherapies, received the European Medicines Agency’s advanced therapy medicinal product certificate for chemistry manufacturing controls data covering its lead product candidate, TAVO (interleukin-12 or "IL-12" plasmid), for the treatment of metastatic melanoma.

Figure 2. Global Europe and Israel Mobile Applications for Melanoma Detection Market Share, By Type, 2020

Key Takeaways of the Graph:

• Among type, the Algorithm Analysis Application held dominant position in the market and accounted for 45.4% share in Europe and Israel mobile applications for melanoma detection market in 2020. The segment is expected to reach US$ 1.85 million in 2028.
• Algorithm Analysis applications are used for risk assessment of pigmented moles, low cost, easy accessibility, and convenient to use are some of the major features to drive this segment during the forecast period
• Among End User, the Patients held dominant position in the market and accounted for 37.7% share in Europe and Israel mobile applications for melanoma detection market in 2020. The segment is expected to reach US$ 1.51 million in 2028.
• Dominance of patients segment can be ascribed to growing demand of mobile applications for melanoma detection among individual end users, easy accessibility for internet & smart phones, and new product launches for mobile users.